hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
Assessing cartilage damage after recurrent ankle sprains

Assessing cartilage damage after recurrent ankle sprains

When does a sprained ankle need more than rest?

Most ankle sprains settle within four to six weeks. The ligaments heal, the swelling clears, and normal activity gradually returns. When that does not happen — when pain lingers past the six-week mark, or when a second or third sprain leaves the ankle feeling worse than the last — that pattern is a prompt to investigate, not a reason to wait longer.

Three specific signs should move the situation from 'rest and reassure' to 'seek structured assessment':

  • Joint-line tenderness on direct pressure, persisting beyond six weeks. Ligament soreness typically fades well before this point; tenderness that remains focused on the joint line suggests something structural may be involved.
  • Mechanical symptoms — catching, clicking, or locking. These sensations can indicate a loose osteochondral fragment moving within the joint, which is a different problem from a stretched ligament.
  • Exercise-related pain that worsens rather than settles. Soft-tissue injuries generally improve with controlled activity; pain that builds with use over weeks is a signal that the underlying tissue is not recovering normally.

Recurrent sprains are not simply cumulative bruising. Each episode loads the cartilage on the top of the talus at abnormal angles, and a 2025 biomechanical analysis found that combined ligament laxity shifts peak stress towards the anteromedial talar dome — a pattern that can constitute a distinct structural injury with every episode. Recognising these signals early and acting on them is not alarmist; it is the appropriate next step.

Why repeated sprains put cartilage at progressive risk

Unlike bone or muscle, cartilage has no blood supply, no lymphatics, and no nerve fibres running through it. When a ligament tears, bleeding draws in repair cells within hours. Cartilage has no equivalent mechanism: chondrocytes sit locked in a dense extracellular matrix and cannot travel to an injury site. Damage, once done, tends to stay done — and, without intervention, tends to grow.

A 2025 micro-indentation study made this concrete at the level of a single sprain. One traumatic impact was sufficient to produce an immediate and measurable fall in cartilage storage and loss moduli — the mechanical properties that allow cartilage to absorb load. The likely explanation is rupture of collagen fibres, which disrupts the proteoglycan network that gives cartilage its resilience. Structural change may begin at the first episode, not only after years of repeated injury.

In a chronically unstable ankle, this deterioration compounds. The anteromedial talar dome — the highest-stress zone once ATFL and CFL laxity are established — continues to bear load at abnormal angles with every step, not just during re-injury events. Clinicians describe this progressive deterioration as the 'ankle cartilage cascade': a self-reinforcing cycle in which instability damages cartilage, altered mechanics increase local stress, and further cartilage loss deepens the instability. Left unaddressed, the cascade can lead to end-stage ankle osteoarthritis. There is also early evidence that patients who already have an osteochondral lesion of the talus show measurably different ankle kinetics during stair descent compared with instability patients who do not — suggesting the joint begins to compensate biomechanically well before symptoms alone reach a clear diagnostic threshold.

Free non-medical discussion

Not sure what to do next?

Book a Discovery Call

Information only · No medical advice or diagnosis.

What a clinical assessment actually involves

A first specialist consultation for a recurrent ankle sprain follows a deliberate sequence — and understanding what the clinician is looking for can help patients describe their symptoms more precisely.

History-taking comes first. The clinician will want to know the exact sequence of sprains, how long each recovery took, and whether symptoms between episodes have been improving, plateauing, or worsening. Crucially, they will ask about mechanical symptoms: catching, clicking, or locking sensations in the ankle. These are not merely discomfort — they raise the specific probability that a fragment of osteochondral tissue has become loose or unstable within the joint, rather than the pain being purely ligamentous in origin.

On examination, direct palpation of the joint line is a key test. Tenderness that persists beyond six weeks, particularly when pressure is applied precisely over the talar dome, points away from soft-tissue healing and towards a structural lesion. The clinician will also perform standard ligament stress tests — the anterior drawer and talar tilt — to map the extent of any instability. These tests are necessary, but they assess ligament integrity only; a completely normal stress test does not exclude cartilage injury.

That is the fundamental limitation of clinical examination alone: it can build a convincing index of suspicion, but it cannot confirm what is happening beneath the cartilage surface or quantify how far a lesion extends. Those questions belong to imaging.

The imaging sequence: from X-ray to MRI

Weight-bearing X-rays are the starting point — they exclude fractures, assess joint alignment, and occasionally reveal a bony fragment or talar dome irregularity when a lesion is large enough to be visible. The limitation is significant: plain radiographs detect only around half of osteochondral lesions of the talus. A clear X-ray does not rule out cartilage damage, which is why investigation cannot stop there when the clinical picture still points to structural injury.

MRI follows as the gold-standard investigation. It identifies bone marrow oedema, maps cartilage layer thickness, and shows the extent of subchondral involvement — findings that X-ray cannot capture. T2-weighted sequences add a further dimension: a high-signal fluid line or cyst behind a fragment indicates an unstable lesion, one where the fragment is at risk of displacement. Stable and unstable lesions follow different management pathways, so this distinction shapes the clinical response from the outset. In practice, the decision to escalate from X-ray to MRI rests on clinical judgement guided by symptom pattern and examination findings, because no validated algorithm yet specifies the precise threshold.

CT scanning is not a first-line tool but becomes valuable in the preoperative setting. It characterises bony morphology, lesion dimensions, and subchondral cyst architecture across multiple planes in ways that MRI cannot match. Its limitation is the inverse: CT does well with bone but cannot reliably resolve purely cartilaginous or non-displaced lesions.

Where MRI findings remain equivocal — particularly when small bony fragments need defining — CT arthrogram is the appropriate step up. Each modality answers a specific question; the sequence is designed so that no single scan has to answer all of them.

Quantitative MRI and early cartilage risk detection

Standard MRI tells a clinician what cartilage looks like; T2 mapping adds a layer beneath that — measuring the biochemical composition of the tissue itself. Cartilage is held together by collagen fibres and water-binding proteoglycans; as these begin to degrade, water molecules move more freely, producing measurably higher T2 relaxation values before any visible structural change appears on a conventional scan.

Research published in 2024 found that patients with chronic lateral ankle instability already show significantly elevated T2 values across multiple medial talar regions — medial anterior, medial centre, and medial posterior — compared with healthy controls, even when their standard MRI appears structurally intact. A 2025 study in 78 patients found that regional T2 patterns also correlate with injury mechanism: supination injuries produce higher medial values, pronation injuries higher lateral values. This raises the possibility that T2 mapping could identify which patients are on a faster deterioration trajectory before a visible lesion forms.

At present, T2 mapping is not available at standard scan centres, and no established thresholds or standardised timing protocols exist for its use in routine ankle assessment. Its most likely near-term role is risk stratification — flagging biochemical deterioration in patients who appear structurally intact on conventional imaging. A specialist who suspects early cartilage compromise in a borderline case may already use this research to justify closer follow-up imaging rather than committing to physiotherapy alone without further review.

Grading the lesion and choosing the next step

Once imaging has identified a lesion, the question shifts from detection to decision: how severe is it, and what does that mean for treatment?

Severity is assessed on two axes. Depth is graded 1 to 4: Grade 1 describes superficial softening of the cartilage surface; Grade 2 involves partial-thickness loss extending less than halfway through the cartilage layer; Grade 3 — which carries four sub-grades — covers damage exceeding 50% of cartilage depth, including penetration to or through the calcified zone; and Grade 4 describes full-thickness loss extending into subchondral bone. Area is categorised broadly as smaller or larger than approximately 2–4 cm², a threshold that reflects the limits of different repair techniques. Both dimensions are needed together — a Grade 2 lesion covering 3 cm² presents a different clinical problem from a Grade 4 lesion of 0.5 cm².

For lower-grade or smaller lesions, the first step is almost always conservative: structured physiotherapy, load modification, and activity adjustment while monitoring symptom trajectory. Many lesions at this stage stabilise without further intervention.

Mid-range lesions — those that fail to settle with conservative care or show biochemical deterioration on imaging — may be candidates for biologic support. Options at this stage include platelet-rich plasma, hyaluronic acid, or injectable collagen scaffold products designed to support matrix-induced chondrogenesis; these can typically be delivered as outpatient, image-guided procedures without a theatre admission.

Larger defects or those involving significant subchondral cyst formation are more likely to require surgical options: microfracture, osteochondral autograft transfer (OATS), or cell-based techniques such as autologous chondrocyte implantation.

The practical implication of this grading logic is straightforward: the earlier a lesion is identified, the broader the treatment menu remains. A Grade 1 lesion caught at six weeks carries options that a Grade 4 lesion identified two years later does not.

  1. [1] Evaluation of Open vs Arthroscopic ATFL Reconstruction for CLAI With Talar Cartilage MRI T2 Mapping — Am J Sports Med 2024. (2024). https://doi.org/10.1177/03635465231222931 https://doi.org/10.1177/03635465231222931
  2. [2] Quantitative T2 Mapping Analysis With MRI of Talar Cartilage in Ankle Trauma — Korean J Radiol 2025. (2025). https://doi.org/10.3348/kjr.2024.0773 https://doi.org/10.3348/kjr.2024.0773
  3. [3] Concomitant OLT Affects In Vivo Ankle Kinetics in Chronic Ankle Instability — Bone Joint Res 2024. (2024). https://doi.org/10.1302/2046-3758.1312.BJR-2023-0217.R2 https://doi.org/10.1302/2046-3758.1312.BJR-2023-0217.R2

Frequently Asked Questions

  • When pain persists past six weeks, or you experience joint-line tenderness, mechanical symptoms like catching or clicking, or exercise-related pain that worsens rather than improves.
  • Each sprain loads the cartilage abnormally, shifting stress towards the anteromedial talar dome. Cartilage lacks blood supply and nerve fibres, so damage cannot self-repair and tends to worsen progressively.
  • History of sprains and mechanical symptoms, palpation of the joint line for tenderness, and ligament stress tests. However, these tests cannot definitively confirm cartilage damage beneath the surface.
  • No. Weight-bearing X-rays detect only around half of osteochondral lesions of the talus. MRI is the gold standard, as it maps cartilage thickness and identifies bone marrow oedema that X-rays cannot capture.
  • T2 mapping measures water content in cartilage, revealing biochemical breakdown before visible structural changes appear on standard imaging. It may identify patients at faster deterioration risk before a lesion forms.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
Assessing cartilage damage after recurrent ankle sprains
30 Aug 2026

Assessing cartilage damage after recurrent ankle sprains

Ankle cartilage has no blood supply and cannot self-repair; each sprain loads it at abnormal angles, and recurrent sprains trigger a self-reinforcing cycle where instability deepens damage, which increases stress and can lead to osteoarthritis.

ChondroFiller injection risks and who qualifies
30 Aug 2026

ChondroFiller injection risks and who qualifies

Across 19,000+ patients, ChondroFiller injection shows zero serious adverse effects and a 3–8% reoperation rate — compared with reported complication rates up to 17% and reoperation rates of 37–41% for surgical alternatives.

ChondroFiller injection for thumb and small hand joint damage
30 Aug 2026

ChondroFiller injection for thumb and small hand joint damage

ChondroFiller injection regenerates focal thumb cartilage defects by recruiting patient cells into acellular scaffolds; a 64-patient two-year prospective study achieved sustained pain relief, functional gains, and zero adverse events.

What your knee cartilage ICRS grade means for treatment
29 Aug 2026

What your knee cartilage ICRS grade means for treatment

Cartilage contains no nerve endings; ICRS grades measure depth, not pain. A shallow Grade 2 lesion under stress can hurt more than a full-thickness Grade 4 defect in a low-load zone.

ChondroFiller injection or PRP for focal cartilage defects
29 Aug 2026

ChondroFiller injection or PRP for focal cartilage defects

ChondroFiller injection and PRP are not alternatives: ChondroFiller fills focal cartilage defects with collagen, whilst PRP modulates joint inflammation through growth factors; diagnosis, not cost, determines the choice.

ChondroFiller repeat dosing and the Lifetime Programme
28 Aug 2026

ChondroFiller repeat dosing and the Lifetime Programme

The Lifetime Preservation Programme manages cartilage defects through three concurrent elements: annual collagen peptide supplementation to sustain avascular cartilage, yearly MRI imaging that adapts injection timing, and repeat ChondroFiller injections every two years. The two-year interval reflects how long the injected collagen scaffold takes to be progressively replaced by the patient's own repair tissue.

Privacy & Cookies Policy